GH1 and chronic obstructive pulmonary disease: A single-center study of patients receiving growth hormone therapy did not identify Covid-related increases in non-adherence (though they did highlight the need for increased caregiver diligence due to supply issues) [20], and increased adherence post-Covid has been reported in a study of 7578 asthma and COPD patients using an inhaler [21].